COVID-19 Vaccine Information
- Latest information on COVID vaccines from FDA
- Latest information on COVID vaccines from the CDC
- WHO updated COVID vaccine guidance (March 2023)
- COVID Vaccine Allergic Reactions/Adverse Events
- Annals Articles
Allergic reactions to the COVID-19 Vaccine (ARCOV) Study: The McGill\University Health Center (MUHC) Experience (May 21, 2022)
What Have We Learned About the Allergenicity and Adverse Reactions Associated With the Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines (April 4, 2022) - CDC Resources
Selected Adverse Events Reported after COVID-19 Vaccination (Updated Jul. 13, 2023)
Allergic Reactions after COVID Vaccination (Updated Jul. 20, 2022) - Other Important Publications
JACI: Adverse Events and Safety of SARS-Cov2 Vaccines: What's New and What's Next (May 9, 2022)
JAMA: Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis (April 1, 2022)
- Annals Articles
COVID-19 Treatment Information
Allergy & Immunology Clinician Resources
- Webinar: What the Allergist Needs to Know about Monoclonal Antibody Therapy
- Managing Your Asthma Patients During COVID (5/28/2020)
- Advice for Wellness, Relaxation and Mental Health During the COVID-19 Pandemic
- ACAAI Statement on COVID-19 & Asthma (3/12/2020)
- GINA Inhaled Asthma Controller Recommendations
- COVID-19 Contingency Planning for the A/I Clinic
- DocMatter (Member Discussion Platform)
Billing & Coding
Reimbursement for telemedicine, waived restrictions
- Coding for Telehealth (5/2022)
Federal Response Updates & Emergency Assistance
Advance payments, loans, payroll protection & more
Overview of COVID-19
- HHS Office for Civil Rights Announces the Expiration of COVID-19 Public Health Emergency HIPAA Notifications of Enforcement Discretion (April 11, 2023)
- End of COVID PHE policy chart – what allergists need to know
- Expiration of COVID HIPAA Enforcement Discretion
- 2023: End of the PHE and the impact on allergists
- Latest Information for Health Care Professionals from CDC
- Symptoms
- Diagnostic & Serologic Testing
From the Journals
- The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review (Annals of Allergy, Asthma & Immunology, January 2023)
- Enhanced SARS-CoV-2 IgG durability following COVID-19 mRNA booster vaccination (Annals of Allergy, Asthma & Immunology, January 2023)
- Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave (Nature, 2023)
- A study in the European Respiratory Journal found an association between individuals with markers of autoimmune disease and long-COVID symptoms
- A letter in Annals reports that split doses of COVID-19 vaccines provided antibody responsiveness
- What have we learned about the allergenicity and adverse reactions associated with the severe acute respiratory syndrome coronavirus 2 vaccines: One year later (Annals of Allergy, Asthma & Immunology, April 2022)
Patient Resources
- Consumer Fact Sheets re coverage for COVID-19 tests after the PHE ends:
- FDA list of at-home COVID tests and extended expiration dates
Telemedicine
- Texas Medical Association End of PHE Telehealth Chart
- Telemedicine How Tos
- Video: How to Bill and Code for a Telemedicine Visit During the COVID-19 Pandemic
- Video: Telemedicine Lessons Learned During the COVID-19 Pandemic
- Video: How to Use Telemedicine With Your Asthma Patients
- Video: How to conduct a professional telemedicine visit
- Video: How to Conduct a Physical Exam via Telemedicine
- State Medical Board Licensing Waivers for Telemedicine
- Coding for Telehealth (May 2022)
- Telehealth Toolkit